ASX - By Stock
|
NEU |
Re:
New Bell Potter Research Update
|
|
nikki
|
31 |
16K |
8 |
10/03/17 |
10/03/17 |
ASX - By Stock
|
31
|
16K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
FAST TRACK - EXPLANATION FROM FDA WEBSITE
|
|
nikki
|
10 |
3.9K |
1 |
08/03/17 |
08/03/17 |
ASX - By Stock
|
10
|
3.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FAST TRACK - EXPLANATION FROM FDA WEBSITE
|
|
nikki
|
10 |
3.9K |
1 |
08/03/17 |
08/03/17 |
ASX - By Stock
|
10
|
3.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FAST TRACK - EXPLANATION FROM FDA WEBSITE
|
|
nikki
|
10 |
3.9K |
1 |
08/03/17 |
08/03/17 |
ASX - By Stock
|
10
|
3.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FAST TRACK - EXPLANATION FROM FDA WEBSITE
|
|
nikki
|
10 |
3.9K |
0 |
08/03/17 |
08/03/17 |
ASX - By Stock
|
10
|
3.9K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MASSIVE PHARMA DEAL
|
|
nikki
|
12 |
5.5K |
2 |
07/03/17 |
07/03/17 |
ASX - By Stock
|
12
|
5.5K
|
2
|
|
ASX - By Stock
|
BNO |
Bell Potter raises their Price Target on BNO
|
|
nikki
|
0 |
1.0K |
6 |
24/02/17 |
24/02/17 |
ASX - By Stock
|
0
|
1.0K
|
6
|
|
ASX - By Stock
|
BNO |
Re:
Biotech set to regain favour
|
|
nikki
|
14 |
5.4K |
2 |
07/02/17 |
07/02/17 |
ASX - By Stock
|
14
|
5.4K
|
2
|
|
ASX - By Stock
|
BNO |
Re:
40M + 10M = 50M = 47c per share
|
|
nikki
|
7 |
5.8K |
1 |
06/02/17 |
06/02/17 |
ASX - By Stock
|
7
|
5.8K
|
1
|
|
ASX - By Stock
|
BNO |
Re:
40M + 10M = 50M = 47c per share
|
|
nikki
|
7 |
5.8K |
0 |
04/02/17 |
04/02/17 |
ASX - By Stock
|
7
|
5.8K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Biotech set to regain favour
|
|
nikki
|
14 |
5.4K |
4 |
04/02/17 |
04/02/17 |
ASX - By Stock
|
14
|
5.4K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
SMH article
|
|
nikki
|
16 |
6.1K |
1 |
03/02/17 |
03/02/17 |
ASX - By Stock
|
16
|
6.1K
|
1
|
|
ASX - By Stock
|
BNO |
Re:
Biotech set to regain favour
|
|
nikki
|
14 |
5.4K |
0 |
03/02/17 |
03/02/17 |
ASX - By Stock
|
14
|
5.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Time to monetize VivaGel BV. Is Pfizer sniffing around
|
|
nikki
|
63 |
17K |
4 |
17/01/17 |
17/01/17 |
ASX - By Stock
|
63
|
17K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Time to monetize VivaGel BV. Is Pfizer sniffing around
|
|
nikki
|
63 |
17K |
2 |
17/01/17 |
17/01/17 |
ASX - By Stock
|
63
|
17K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Thus spoke the Professor
|
|
nikki
|
23 |
7.1K |
2 |
13/01/17 |
13/01/17 |
ASX - By Stock
|
23
|
7.1K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
ADR volume etc
|
|
nikki
|
17 |
5.3K |
4 |
13/01/17 |
13/01/17 |
ASX - By Stock
|
17
|
5.3K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
The All-Important Appendix 3C
|
|
nikki
|
9 |
2.1K |
0 |
13/01/17 |
13/01/17 |
ASX - By Stock
|
9
|
2.1K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
The All-Important Appendix 3C
|
|
nikki
|
9 |
2.1K |
5 |
12/01/17 |
12/01/17 |
ASX - By Stock
|
9
|
2.1K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Break Out
|
|
nikki
|
68 |
23K |
9 |
11/01/17 |
11/01/17 |
ASX - By Stock
|
68
|
23K
|
9
|
|
ASX - By Stock
|
MVP |
Re:
Herald Sun
|
|
nikki
|
12 |
3.8K |
0 |
10/01/17 |
10/01/17 |
ASX - By Stock
|
12
|
3.8K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Herald Sun
|
|
nikki
|
12 |
3.8K |
0 |
09/01/17 |
09/01/17 |
ASX - By Stock
|
12
|
3.8K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Herald Sun
|
|
nikki
|
12 |
3.8K |
0 |
09/01/17 |
09/01/17 |
ASX - By Stock
|
12
|
3.8K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Penthrox approved for sale in Taiwan
|
|
nikki
|
29 |
7.0K |
2 |
09/12/16 |
09/12/16 |
ASX - By Stock
|
29
|
7.0K
|
2
|
|
ASX - By Stock
|
BNO |
Re:
Constant investor
|
|
nikki
|
7 |
5.3K |
6 |
26/09/16 |
26/09/16 |
ASX - By Stock
|
7
|
5.3K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Present at Ophthalmology Innovation Summit in US-OPT.AX
|
|
nikki
|
15 |
5.5K |
3 |
13/09/16 |
13/09/16 |
ASX - By Stock
|
15
|
5.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Agreements to be concluded for VivaGel® portfolio of products shortly
|
|
nikki
|
14 |
2.7K |
1 |
20/07/16 |
20/07/16 |
ASX - By Stock
|
14
|
2.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma, condoms, Zika virus and Ansell
|
|
nikki
|
47 |
16K |
5 |
06/05/16 |
06/05/16 |
ASX - By Stock
|
47
|
16K
|
5
|
|
ASX - By Stock
|
BNO |
Re:
Technical breakout imminent?
|
|
nikki
|
21 |
5.8K |
0 |
04/05/16 |
04/05/16 |
ASX - By Stock
|
21
|
5.8K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Technical breakout imminent?
|
|
nikki
|
21 |
5.8K |
0 |
04/05/16 |
04/05/16 |
ASX - By Stock
|
21
|
5.8K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Technical breakout imminent?
|
|
nikki
|
21 |
5.8K |
0 |
04/05/16 |
04/05/16 |
ASX - By Stock
|
21
|
5.8K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Update
|
|
nikki
|
19 |
8.0K |
3 |
26/04/16 |
26/04/16 |
ASX - By Stock
|
19
|
8.0K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Ph1 wAMD Trial with OPT-302 Meets Primary Objective-OPT.AX
|
|
nikki
|
5 |
2.4K |
3 |
22/04/16 |
22/04/16 |
ASX - By Stock
|
5
|
2.4K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: First subject commences Neuren's Rett syndrome Phase 2 trial-NEU.AX
|
|
nikki
|
14 |
9.1K |
0 |
08/04/16 |
08/04/16 |
ASX - By Stock
|
14
|
9.1K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: First subject commences Neuren's Rett syndrome Phase 2 trial-NEU.AX
|
|
nikki
|
14 |
9.1K |
1 |
08/04/16 |
08/04/16 |
ASX - By Stock
|
14
|
9.1K
|
1
|
|
ASX - By Stock
|
OPT |
Re:
Anyone following OPT (CIR) in Hotcopper now?
|
|
nikki
|
33 |
14K |
3 |
18/01/16 |
18/01/16 |
ASX - By Stock
|
33
|
14K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Takeover Acceptance Level?
|
|
nikki
|
29 |
7.7K |
0 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
29
|
7.7K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Buy close to 7th Dec
|
|
nikki
|
18 |
4.8K |
0 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
18
|
4.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
0 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
194
|
48K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
2 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
194
|
48K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
2 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
194
|
48K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
0 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
194
|
48K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
2 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
194
|
48K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
1 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
194
|
48K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
1 |
24/11/15 |
24/11/15 |
ASX - By Stock
|
194
|
48K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
0 |
23/11/15 |
23/11/15 |
ASX - By Stock
|
194
|
48K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
2 |
23/11/15 |
23/11/15 |
ASX - By Stock
|
194
|
48K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter downgrade 23 November 2015
|
|
nikki
|
194 |
48K |
4 |
23/11/15 |
23/11/15 |
ASX - By Stock
|
194
|
48K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
VivaGel® patent till 2032 gives Starpharma another leg up
|
|
nikki
|
18 |
3.5K |
6 |
15/10/15 |
15/10/15 |
ASX - By Stock
|
18
|
3.5K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: IRSF confirms financial support for Neuren's clinical trials
|
|
nikki
|
9 |
4.0K |
13 |
14/10/15 |
14/10/15 |
ASX - By Stock
|
9
|
4.0K
|
13
|
|